Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Cyclerion Therapeutics Inc | CYCN | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
2.86 | 2.86 | 2.86 | 2.86 | 2.7701 |
Recent News
Date | Time | Source | Heading |
---|---|---|---|
08/5/2024 | 06:30 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
27/1/2024 | 08:05 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
12/12/2023 | 09:09 | EDGAR2 | Form 3 - Initial statement of beneficial ownership of.. |
05/12/2023 | 09:09 | EDGAR2 | Form 8-K - Current report |
05/12/2023 | 00:00 | GLOBE | Cyclerion Appoints Regina Graul, Ph.D., as President |
02/12/2023 | 00:01 | EDGAR2 | Form 8-K - Current report |
01/12/2023 | 10:16 | GLOBE | Cyclerion Strengthens Board of Directors with Experienced.. |
25/11/2023 | 05:06 | EDGAR2 | Form 8-K - Current report |
14/11/2023 | 08:30 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
24/10/2023 | 07:58 | EDGAR2 | Form 8-K - Current report |
31/7/2023 | 21:00 | GLOBE | Tisento Launches with $81 Million From Top-Tier Investor.. |
29/7/2023 | 06:48 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
20/7/2023 | 07:27 | EDGAR2 | Form 8-K - Current report |
13/7/2023 | 06:12 | EDGAR2 | Form 8-K - Current report |